Travere Therapeutics, Inc. TVTX
Price alert —
Sign in to get a one-time email the moment TVTX crosses your price. Free accounts included.
Sign in / create a free accountTravere Therapeutics, Inc. is a healthcare company listed in the US.
TVTX last traded at $56.71, up 2.6% on the day; that's in the upper part of its 52-week range ($26.15–$60.10). Right now it's trading close to its recent average, with no strong stretch in either direction.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 58), the trend is strong (ADX 33), and trading is light at 0.7× normal volume. On the business side, revenue is growing 56% year over year and the business keeps about -10 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Quick ratio 2.16 (antifragile)
- ✓ Current ratio 2.74 (antifragile)
- ✓ Gross margin 56% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Debt/equity 4.27 (fragile)
- ⚠ Negative retained earnings
- ⚠ Receivables growing faster than revenue
TVTX is a $5.3 billion company, the stock is trading near the top of its 52-week range.